Biopharma

X-ray showing colon cancer
#Biopharma #Cancer #FDA

Alnodesertib granted fast track designation by the FDA

The ATR inhibitor alnodesertib has been granted fast track designation by the US Food and Drug Administration (FDA), biopharmaceutical company Artios Pharma Limited has announced.  Alnodesertib is a treatment for adult patients with ATM negative metastatic colorectal cancer (mCRC) in the third-line setting, in combination with a… Read More

#News

Vaccine
#AI #Antibody drug conjugate (ADC) #Biopharma #Drug discovery #Vaccines

DDW Fall issue out now

The DDW Fall issue is out now and examines why there is a need for a universal pneumococcal vaccine, why China might be the next global biopharma powerhouse and looks at developments in microbiome research and the therapeutic sectors it is driving. It also features an exclusive guide exploring… Read More

#News

#Biopharma #Drug discovery #Life sciences #Start-ups

Pioneer and AbbVie team up on a Golden Ticket to accelerate human health 

Pioneer Group, a specialist in life science infrastructure and venture building, has again teamed up with biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology. Read More

#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: The impact of digital pathology and AI on drug discovery

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Scientist using a laptop
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: Hear from companies at the forefront of digital pathology

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Histology slides
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: Biopharma and the shift to computational pathology

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Computer in laboratory
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: How pathology AI is transforming biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: The strategic power of pathology and AI for biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology

Rewiring drug development: The strategic power of pathology and AI for biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#Webinars

#Artificial intelligence (AI) #Biopharma #Biotechnology #Drug discovery #Genetics / genomics

DDW Summer edition – out now!

The DDW Summer issue is available to read now. It features in-depth articles on the technologies and advancements driving genomics drug discovery, how supercomputing can drive neuroscience discoveries, and everything you need to know about spatial biology.  Other features include:   A market report on… Read More

#Editor's Choice #News

#Biomanufacturing #Biopharma #Collaboration #UK

UK business and academia partner on innovative biopharma research

Twenty-three new Prosperity Partnerships will tackle key industry challenges in areas from drug manufacturing and artificial intelligence to cybersecurity. The UKRI Engineering and Physical Sciences Research Council (EPSRC) is funding the partnerships with a £41 ($55.7) million investment, matched with a further £56 ($76) million from businesses and academia.  Each… Read More

#Business & Investment #News

#App note #Biopharma #Drug development

New guide: Unlocking the biopharma development pipeline

A new Introductory Guide is now available for download entitled ‘Unlocking the biopharma development pipeline‘. Discover a new generation of molecular sensing technology from Oxford Nanopore Technologies that is transforming the biopharma development pipeline. You’ll explore: How Oxford Nanopore sequencing overcomes challenges faced in the drug development process Advantages… Read More

#News

#App note #Biopharma #Drug development

Unlocking the biopharma development pipeline

A new Introductory Guide is now available for download entitled ‘Unlocking the biopharma development pipeline‘. Discover a new generation of molecular sensing technology from Oxford Nanopore Technologies that is transforming the biopharma development pipeline. You’ll explore: How Oxford Nanopore sequencing overcomes challenges faced in the drug development process Advantages… Read More

#Resources

#Biopharma #Drug development #Drug discovery #Oncology #Partnership

Sanofi and Orano invest in potential of radioligand cancer medicines 

Sanofi and Orano Med have entered into an agreement with the aim of accelerating the development of radioligand medicines.  Building on the radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand.  The new entity… Read More

#News

#Biopharma #Digitalisation #Drug development #Drug discovery

How “digitally mature” is your pharma company? 

By Craig Williamson, Lead Platform Product Manager, Integrations Strategy at IDBS.   The biopharma industry is changing. Companies with mature digital approaches are achieving operational efficiencies and breakthroughs in R&D. Companies that don’t risk being left behind.   Digital maturity is not just about collecting data, but about making data truly useful:… Read More

#Exclusive Content

Laboratory research
#Biopharma #Biopharmaceuticals #Career #Great Place To Work

Biopharma amongst top-ranking sectors for employee wellbeing

Biopharma ranks amongst the highest scoring sectors for employee wellbeing and comes top for work-life balance and self-care, according to a survey conducted by Great Place To Work. Leveraging their research-based Trust Index Survey, Great Place To Work conducted a UK population study, surveying 2,200 employees… Read More

#News